Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abeona Therapeutics (ABEO)

2.75   -0.08 (-2.83%) 08-14 16:00
Open: 2.83 Pre. Close: 2.83
High: 2.83 Low: 2.71
Volume: 719,540 Market Cap: 233M
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.833 - 2.851 2.851 - 2.864
Low: 2.669 - 2.69 2.69 - 2.706
Close: 2.721 - 2.753 2.753 - 2.776

Technical analysis

as of: 2020-08-14 4:26:57 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.51     One year: 3.73
Support: Support1: 2.71    Support2: 2.25
Resistance: Resistance1: 3.01    Resistance2: 3.19
Pivot: 2.89
Moving Average: MA(5): 2.88     MA(20): 2.91
MA(100): 2.79     MA(250): 2.76
MACD: MACD(12,26): -0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 27.27     %D(3): 38.80
RSI: RSI(14): 42.12
52-week: High: 5.19  Low: 1.35  Change(%): 23.3
Average Vol(K): 3-Month: 85335  10-Days: 53723

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ABEO has closed above bottom band by 2.9%. Bollinger Bands are 56.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABEO's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 12 Aug 2020
Edited Transcript of ABEO earnings conference call or presentation 11-Aug-20 12:30pm GMT -

Wed, 12 Aug 2020
Abeona Therapeutics (ABEO) Gets a Hold Rating from Mizuho Securities - Smarter Analyst

Tue, 11 Aug 2020
Should You Buy Abeona Therapeutics Inc (ABEO) Stock? - InvestorsObserver

Mon, 10 Aug 2020
Abeona Therapeutics: 2Q Earnings Snapshot - Albuquerque Journal

Mon, 10 Aug 2020
Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates - GlobeNewswire

Fri, 07 Aug 2020
Need To Know: Abeona Therapeutics Inc. (NASDAQ:ABEO) Insiders Have Been Buying Shares - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 84
Shares Float (M) 70
% Held by Insiders 17.82
% Held by Institutions 66.40
Shares Short (K) 3,040
Shares Short P. Month (K) 2,170

Stock Financials

EPS -1.721
EPS Est This Year -0.700
EPS Est Next Year -0.770
Book Value (p.s.) 1.580
Profit Margin
Operating Margin
Return on Assets (ttm) -26.9
Return on Equity (ttm) -84.7
Qtrly Rev. Growth
Gross Profit (p.s.) -0.581
Sales Per Share
EBITDA (p.s.) -0.779
Qtrly Earnings Growth
Operating Cash Flow (M) -61
Levered Free Cash Flow (M) -19

Stock Valuations

PE Ratio -1.60
PEG Ratio
Price to Book value 1.74
Price to Sales
Price to Cash Flow -3.77

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.